MoneyWorks4Me

Biogen Pharmachem - Quaterly Results

01 Aug 2024 Evaluate
The Sales for the quarter ended June 2024 of Rs. -0.91 million declined by -112.08% from Rs. 7.53 millions.The Net Loss for the quarter ended June 2024 is Rs. -1.59 millions as compared to Net Profit of Rs. 4.06 millions of corresponding quarter ended June 2023Operating profit Margin for the quarter ended June 2024 slipped to -1.59% as compared to 4.06% of corresponding quarter ended June 2023


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202406 202306 % Var 202406 202306 % Var 202403 202303 % Var
Sales -0.91 7.53 -112.08 -0.91 7.53 -112.08 23.82 9.13 160.90
Other Income 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBIDT -1.59 4.06 -139.16 -1.59 4.06 -139.16 19.31 4.56 323.46
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBDT -1.59 4.06 -139.16 -1.59 4.06 -139.16 19.31 4.56 323.46
Depreciation 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBT -1.59 4.06 -139.16 -1.59 4.06 -139.16 19.31 4.56 323.46
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT -1.59 4.06 -139.16 -1.59 4.06 -139.16 19.31 4.56 323.46
Equity 652.60 652.60 0.00 652.60 652.60 0.00 652.60 652.60 0.00
PBIDTM(%) 174.73 53.92 224.06 174.73 53.92 224.06 81.07 49.95 62.31
Peers
Company Name CMP
Redington 392.20
Amrapali Industries 37.05
Adani Enterprises 3100.00
Rashi Peripheral 805.00
PDS 348.90
View more..